Results 201 to 210 of about 122,545 (272)

Mapping the Treatment Journey of Children on Subcutaneous House Dust Mite Immunotherapy: A Qualitative Study. [PDF]

J Multidiscip Healthc
Xu S, Gu Z, Zhao J, Xu J, Xie J.
europepmc   +1 more source

Adverse Childhood Experiences in Autistic and Neurotypical Girls

Autism Research, EarlyView.
ABSTRACT Adverse childhood experiences (ACEs) are potentially traumatic, life‐altering events that occur in childhood with long‐term negative physical and/or mental health outcomes. Previous research, while limited and largely focused on males, suggests children with autism spectrum disorder (ASD) are at higher risk of experiencing ACEs than typically ...
Jon Ebert, Rachael A. Muscatello, Trey McGonigle, Simon Vandekar, Blythe A. Corbett   +4 more
wiley   +1 more source

Using journey mapping to understand the experience and need for patients with chimeric antigen receptor T-cell therapy. [PDF]

Asia Pac J Oncol Nurs
Liu M, Pan J, Li H, Xie C, Fan Y, Fang Y.   +5 more
europepmc   +1 more source

Prescribing competence: The pros and cons of different methods for assessment

British Journal of Clinical Pharmacology, EarlyView.
Evaluating a medical graduate’s competence in rational prescribing is challenging. With the aim to guide and inspire teachers, this narrative review explores different methods that can be used to assess prescribing competence. Each method has its own advantages and disadvantages, and thus a mix of different assessment methods is needed throughout the ...
David J. Brinkman, Erik M. Donker, Jelle Tichelaar, on behalf of the CP4T programme   +3 more
wiley   +1 more source

Applying journey mapping and human-centered design to improve critical care delivery for patients with acute respiratory failure. [PDF]

BMC Health Serv Res
Golden SE, Lyons PG, Young A, Warner S, Tuepker A, Ilea I, Sullivan DR, Slatore CG, Vranas KC.   +8 more
europepmc   +1 more source

Switching disease‐modifying therapies in patients with spinal muscular atrophy: A systematic review on effectiveness outcomes

British Journal of Clinical Pharmacology, EarlyView.
With multiple disease‐modifying therapies now available, treatment switching has become an important clinical consideration in the management of spinal muscular atrophy (SMA). While some switches are prompted by suboptimal clinical response, more commonly they are driven by treatment burden, convenience, or adverse events.
Andrej Belančić, Elvira Meni Maria Gkrinia, Patrick Eustaquio, Andrea Katrin Faour, Dinko Vitezić   +4 more
wiley   +1 more source

Understanding opioid use within the substance use journeys of adults receiving treatment: a qualitative study protocol of the participant-led timeline mapping approach. [PDF]

BMJ Open
Estrella MJ, Wells S, Foy R, Quilty L, Bozinoff N, Buckley L, Lincoln S, Patenaude S, Ali F.   +8 more
europepmc   +1 more source

Optimization of pharmaceutical research and development by early‐phase assessment of investigational medicinal products

British Journal of Clinical Pharmacology, EarlyView.
Small and mid‐sized pharmaceutical innovators often have limited in‐house health economics and market access expertise, and may struggle to align development strategies of investigational medicinal products with health system needs and payer expectations.
Zoltán Kaló, Attila Imre, Gábor Varga, Sándor Kovács, György Tímár, Balázs Nagy   +5 more
wiley   +1 more source

Visualisation of a complex healthcare system: mapping vascular and trauma surgery services in Ghana. [PDF]

BMC Health Serv Res
Amoako J, Bath MF, Wordui T, Ametefe EK, Komashie A, Kohler K, Kyei MK, Bashford T, GOAL-Trauma Collaborative Ghana.   +8 more
europepmc   +1 more source

Following the youth patient journey in the mental health help-seeking process in Bogotá, Colombia. [PDF]

Int J Ment Health Syst
Shambo-Rodríguez DL, Riaño-Fonseca MI, Camacho S, Rueda-Jaimes GE, Sánchez-Nítola MN, Chocontá AM, Gómez Restrepo C, Martin Hilber A, Navarro-Mancilla ÁA, Hickie IB, Occhipinti JA, Ospina-Pinillos L.   +11 more
europepmc   +1 more source